Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $45,100 | 28 | 79.0% |
| Food and Beverage | $7,408 | 344 | 13.0% |
| Travel and Lodging | $4,399 | 19 | 7.7% |
| Education | $148.30 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $51,597 | 154 | $0 (2024) |
| ABBVIE INC. | $629.76 | 26 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $561.48 | 14 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $542.15 | 26 | $0 (2023) |
| Genentech USA, Inc. | $537.58 | 31 | $0 (2022) |
| UCB, Inc. | $495.83 | 31 | $0 (2024) |
| Janssen Biotech, Inc. | $438.85 | 26 | $0 (2023) |
| Horizon Therapeutics plc | $375.96 | 14 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $365.22 | 9 | $0 (2023) |
| Genentech, Inc. | $296.76 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $986.58 | 17 | Amgen Inc. ($907.60) |
| 2023 | $716.38 | 25 | AstraZeneca Pharmaceuticals LP ($199.40) |
| 2022 | $6,986 | 43 | Amgen Inc. ($6,618) |
| 2021 | $6,950 | 43 | Amgen Inc. ($6,445) |
| 2020 | $4,696 | 34 | Amgen Inc. ($4,283) |
| 2019 | $30,729 | 116 | Amgen Inc. ($29,058) |
| 2018 | $5,243 | 72 | Amgen Inc. ($4,037) |
| 2017 | $748.68 | 45 | Amgen Inc. ($167.05) |
All Payment Transactions
395 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Bone Health | ||||||
| 11/12/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/15/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Immunology | ||||||
| 07/23/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Bone Health | ||||||
| 05/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: IMMUNOLOGY | ||||||
| 04/30/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/02/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: Bone Health | ||||||
| 03/05/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: Bone Health | ||||||
| 03/05/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 02/29/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $4.47 | General |
| Category: Inflammation | ||||||
| 02/18/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $200.00 | General |
| Category: Bone Health | ||||||
| 02/08/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Bone Health | ||||||
| 01/11/2024 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $88.87 | General |
| Category: Dermatology | ||||||
| 11/11/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $108.74 | General |
| 11/06/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.70 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Bone Health | ||||||
| 10/12/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Education | In-kind items and services | $43.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/10/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: KRYSTEXXA | ||||||
| 09/28/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Dermatology | ||||||
| 09/14/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 42 | 2,990 | 198,142 | $3.0M | $1.9M |
| 2022 | 44 | 3,198 | 158,386 | $2.7M | $1.8M |
| 2021 | 42 | 3,527 | 116,796 | $2.4M | $1.6M |
| 2020 | 45 | 3,373 | 135,482 | $2.6M | $1.8M |
All Medicare Procedures & Services
173 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 26 | 29,100 | $711,246 | $503,072 | 70.7% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 21 | 57,840 | $376,631 | $261,220 | 69.4% |
| J9312 | Injection, rituximab, 10 mg | Office | 2023 | 18 | 3,900 | $373,339 | $247,835 | 66.4% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 30 | 20,768 | $390,581 | $216,581 | 55.5% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 29 | 6,370 | $249,218 | $167,554 | 67.2% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 14 | 33,600 | $341,900 | $131,116 | 38.3% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 11 | 3,150 | $157,082 | $106,041 | 67.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 76 | 5,520 | $128,425 | $98,935 | 77.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 389 | 499 | $66,568 | $41,514 | 62.4% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 25 | 33,000 | $44,093 | $28,753 | 65.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 146 | 425 | $30,074 | $19,677 | 65.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 51 | 160 | $21,977 | $14,931 | 67.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 291 | 582 | $7,185 | $5,999 | 83.5% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 49 | 241 | $7,089 | $4,976 | 70.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $7,448 | $4,856 | 65.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 304 | 604 | $5,458 | $4,578 | 83.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 106 | 328 | $4,793 | $3,511 | 73.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 113 | 120 | $4,107 | $3,481 | 84.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 60 | 60 | $2,391 | $2,275 | 95.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 43 | $4,059 | $2,119 | 52.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 18 | $3,299 | $1,997 | 60.5% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 57 | 146 | $2,397 | $1,691 | 70.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 26 | 30 | $2,244 | $1,630 | 72.6% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 201 | 291 | $1,831 | $1,478 | 80.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 276 | 388 | $1,446 | $1,403 | 97.1% |
About Dr. Jennifer May, MD
Dr. Jennifer May, MD is a Internal Medicine healthcare provider based in Rapid City, South Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891765475.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer May, MD has received a total of $57,056 in payments from pharmaceutical and medical device companies, with $986.58 received in 2024. These payments were reported across 395 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($45,100).
As a Medicare-enrolled provider, May has provided services to 13,088 Medicare beneficiaries, totaling 608,806 services with total Medicare billing of $7.1M. Data is available for 4 years (2020–2023), covering 173 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Rapid City, SD
- Active Since 01/25/2006
- Last Updated 06/30/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1891765475
Products in Payments
- Prolia (Biological) $32,371
- EVENITY (Biological) $18,439
- Enbrel (Biological) $688.17
- Cimzia (Drug) $495.83
- Rituxan (Biological) $493.14
- COSENTYX (Biological) $380.92
- KRYSTEXXA (Biological) $350.43
- KEVZARA SARILUMAB INJECTION (Biological) $332.56
- KEVZARA (Biological) $228.92
- Actemra (Biological) $223.93
- BENLYSTA (Biological) $217.98
- Otezla (Drug) $209.06
- SIMPONI ARIA (Biological) $201.00
- Humira (Biological) $177.53
- ACTHAR (Biological) $171.35
- SAPHNELO (Biological) $165.82
- TREMFYA (Drug) $162.25
- TALTZ (Drug) $145.96
- COSENTYX (Drug) $140.95
- LUPKYNIS (Drug) $91.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rapid City
Dr. Richard Beasley, Md, MD
Internal Medicine — Payments: $54,827
Dr. Ali Zakaria, M.d, M.D
Internal Medicine — Payments: $18,557
Cliff Janikowski
Internal Medicine — Payments: $6,375
David Evans, Md, MD
Internal Medicine — Payments: $5,186
Andrew Kelts, D.o, D.O
Internal Medicine — Payments: $4,136
Dr. Stephen Wasemiller, M.d, M.D
Internal Medicine — Payments: $1,214